Chemoinformaics analysis of LANOST-8-EN-3-BETA-OL
| Molecular Weight | 470.782 | nRot | 6 |
| Heavy Atom Molecular Weight | 416.35 | nRig | 21 |
| Exact Molecular Weight | 470.412 | nRing | 4 |
| Solubility: LogS | -6.988 | nHRing | 0 |
| Solubility: LogP | 8.101 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 88 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 91.0508 |
| nHD | 0 | BPOL | 56.7772 |
| QED | 0.286 |
| Synth | 4.486 |
| Natural Product Likeliness | 2.921 |
| NR-PPAR-gamma | 0.356 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.882 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.828 |
| MDCK | 0.00000883 |
| BBB | 0.127 |
| PPB | 0.966543 |
| VDSS | 2.588 |
| FU | 0.0131181 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.415 |
| CYP2c19-inh | 0.084 |
| CYP2c19-sub | 0.979 |
| CYP2c9-inh | 0.084 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.144 |
| CYP3a4-inh | 0.293 |
| CYP3a4-sub | 0.727 |
| CL | 5.932 |
| T12 | 0.007 |
| hERG | 0.008 |
| Ames | 0.013 |
| ROA | 0.015 |
| SkinSen | 0.07 |
| Carcinogencity | 0.013 |
| EI | 0.119 |
| Respiratory | 0.747 |
| NR-Aromatase | 0.399 |
| Antiviral | No |
| Prediction | 0.73472 |